FDA approves Cara’s drug for severe itching in kidney disease patients
FDA approves Cara’s drug for severe itching in kidney disease patients
The Food and Drug Administration on Monday approved Cara Therapeutics’s drug to treat moderate-to-severe itching in patients with chronic kidney disease undergoing dialysis, making it the first therapy for the ailment in the United States. Read More